Basiliximab Completed Phase 4 Trials for Liver Cirrhosis / Liver Transplant Disorder Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00296244Steroid Free Immunosuppression in Liver Transplantation